+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Psychosis"

Mental Health Global Market Report 2024 - Product Thumbnail Image

Mental Health Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
From
Cannabis-Induced Psychosis (CIP) - Pipeline Insight, 2024 - Product Thumbnail Image

Cannabis-Induced Psychosis (CIP) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Parkinson's disease psychosis - Pipeline Insight, 2024, - Product Thumbnail Image

Parkinson's disease psychosis - Pipeline Insight, 2024,

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Psychosis Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Psychosis Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 290 Pages
  • Global
From
Loading Indicator

Psychosis is a mental health disorder characterized by a loss of contact with reality. Symptoms of psychosis can include delusions, hallucinations, disorganized thinking, and changes in behavior. It is often associated with schizophrenia, bipolar disorder, and other mental health conditions. Treatment for psychosis typically involves a combination of medication, psychotherapy, and lifestyle changes. The psychosis market is a subset of the larger mental health market. It is composed of companies that provide products and services related to the diagnosis, treatment, and management of psychosis. These products and services include medications, psychotherapy, and lifestyle interventions. Additionally, companies in the psychosis market may provide support services such as patient education, advocacy, and community outreach. Some companies in the psychosis market include Otsuka Pharmaceuticals, Sunovion Pharmaceuticals, and Lundbeck. Show Less Read more